Aqr Capital Management LLC Evelo Biosciences, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.07 - $12.0 $147,652 - $291,900	-24,325 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.79 - $13.9 $76,272 - $156,138	11,233 Added 85.8%	24,325 $171,000
Q2 2021 Aug 16, 2021	SELL	$9.43 - $16.6 $326,428 - $574,625	-34,616 Reduced 72.56%	13,092 $180,000
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $463,244 - $887,368	47,708 New	47,708 $510,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.